Weiss Amir
- SEC CIK
- 0001897057
In the past year, 4 open-market sale filings worth $1.41M and no purchases.
Current role at each company
- TEVA Teva Pharmaceutical Industries LtdChief Accounting Officeras of Aug 25, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.41M
- 4 filings
- Net
- −$1.41M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Weiss Amir as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 (view filing)4:05 PM ET | Aug 21 | 4 days | Weiss AmirChief Accounting Officer | SSale | −9.45K | $37.62 | −$355.3K | −41.9%13.1K after | 2 lots |
| May 7, 2026 (view filing) | May 6 | 1 day | Weiss AmirChief Accounting Officer | SSale | −10.7K | $36.00 | −$384.4K | −34.8%20.0K after | |
| Dec 18, 2025 (view filing) | Dec 16 | 2 days | Weiss AmirChief Accounting Officer | SSale | −12.3K | $30.20 | −$371.5K | −68.5%5.65K after | |
| Nov 10, 2025 (view filing) | Nov 6 | 4 days | Weiss AmirChief Accounting Officer | SSale | −12.3K | $24.44 | −$300.6K | −40.7%17.9K after | |
| May 17, 2024 (view filing) | May 15-16 | 2 days | Weiss AmirChief Accounting Officer | SSale | −28.1K | $16.73 | −$470.8K | −84.5%5.18K after | 2 lots |
| Feb 5, 2024 (view filing) | Feb 1 | 4 days | Weiss AmirChief Accounting Officer | SSale | −31.8K | $12.37 | −$392.9K | −74.8%10.7K after | |
| Aug 7, 2023 (view filing) | Aug 4 | 3 days | Weiss AmirChief Accounting Officer | SSale | −1.98K | $9.92 | −$19.7K | −4.5%42.4K after |